Literature DB >> 21056300

NMDA receptor antagonists and pain: ketamine.

William W Muir1.   

Abstract

N-Methyl-D-aspartate (NMDA) is a synthetic chemical binding molecule (ligand) that selectively binds to the "slow response" glutamate NMDA receptor (NMDAR). NMDARs are important for normal brain function and play a central role in learning, memory, and the development of central nervous system hyperactive states. Diverse chemicals belonging to various drug families have demonstrated NMDAR antagonistic effects. Ketamine has been shown to produce antihyperalgesic effects produced by incision and tissue or nerve damage, and has become popular in equine practice as an anesthetic and more recently as an analgesic for standing surgical procedures and the treatment of laminitis. This review focuses on the development of ketamine as an anesthetic and analgesic in horses.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21056300     DOI: 10.1016/j.cveq.2010.07.009

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN: 0749-0739            Impact factor:   1.792


  10 in total

1.  Influence of prior determination of baseline minimum alveolar concentration (MAC) of isoflurane on the effect of ketamine on MAC in dogs.

Authors:  Giacomo Gianotti; Alexander Valverde; Ron Johnson; Melissa Sinclair; Thomas Gibson; Doris H Dyson
Journal:  Can J Vet Res       Date:  2014-07       Impact factor: 1.310

2.  Ketamine Alleviates Fear Generalization Through GluN2B-BDNF Signaling in Mice.

Authors:  Muhammad Asim; Bo Hao; Yu-Han Yang; Bu-Fang Fan; Li Xue; Yan-Wei Shi; Xiao-Guang Wang; Hu Zhao
Journal:  Neurosci Bull       Date:  2019-08-23       Impact factor: 5.203

3.  Ketamine-Induced Toxicity in Neurons Differentiated from Neural Stem Cells.

Authors:  William Slikker; Fang Liu; Shuo W Rainosek; Tucker A Patterson; Natalya Sadovova; Joseph P Hanig; Merle G Paule; Cheng Wang
Journal:  Mol Neurobiol       Date:  2015-06-09       Impact factor: 5.590

4.  Behavioral effects of prenatal ketamine exposure in rhesus macaques are dependent on MAOA genotype.

Authors:  John P Capitanio; Laura A Del Rosso; Laura A Calonder; Shelley A Blozis; M Cecilia T Penedo
Journal:  Exp Clin Psychopharmacol       Date:  2012-01-16       Impact factor: 3.157

5.  Parasympathetic Tone Changes in Anesthetized Horses after Surgical Stimulation, and Morphine, Ketamine, and Dobutamine Administration.

Authors:  Patricia Ruíz-López; Juan Morgaz; Setefilla Quirós-Carmona; Rocío Navarrete-Calvo; Juan Manuel Domínguez; Rafael Jesús Gómez-Villamandos; M M Granados
Journal:  Animals (Basel)       Date:  2022-04-15       Impact factor: 3.231

6.  Activation of c-jun N-terminal kinase in spinal cord contributes to breast cancer induced bone pain in rats.

Authors:  Xiao-Wei Wang; Shan Hu; Qi-Liang Mao-Ying; Qian Li; Chang-Jiang Yang; Hui Zhang; Wen-Li Mi; Gen-Cheng Wu; Yan-Qing Wang
Journal:  Mol Brain       Date:  2012-06-09       Impact factor: 4.041

7.  Use of Nasotracheal Intubation during General Anesthesia in Two Ponies with Tracheal Collapse.

Authors:  Keila K Ida; Aurélie Sauvage; Alexandra Gougnard; Magda Grauwels; Didier Serteyn; Charlotte Sandersen
Journal:  Front Vet Sci       Date:  2018-03-13

8.  Low-dose Ketamine Does Not Improve Migraine in the Emergency Department: A Randomized Placebo-controlled Trial.

Authors:  Ashley R Etchison; Lia Bos; Meredith Ray; Kelly B McAllister; Moiz Mohammed; Barrett Park; Allen Vu Phan; Corey Heitz
Journal:  West J Emerg Med       Date:  2018-09-10

9.  Effect of Intervenous Magnesium Sulfate on Decreasing Opioid Requirement after Surgery of the Lower Limb Fracture by Spinal Anesthesia.

Authors:  Hamid Kayalha; Siamak Yaghoubi; Zohreh Yazdi; Parastoo Izadpanahi
Journal:  Int J Prev Med       Date:  2019-05-06

10.  Efficacy of Resveratrol in Experimental Subarachnoid Hemorrhage Animal Models: A Stratified Meta-Analysis.

Authors:  Jiahe Tan; Rui Song; Siyue Luo; Wenqiao Fu; Yinrui Ma; Lian Zheng; Zhaohui He
Journal:  Front Pharmacol       Date:  2022-06-29       Impact factor: 5.988

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.